Regulating The CGT Workflow To Improve Patient Safety: Audience Q&A

At the conclusion of the presentation, our expert panelists, Nimi Chhina, Ph.D., J.D. Executive Director, Head of Global R&D and Regulatory Policy Global Regulatory Affairs, Worldwide Research & Development at BioMarin Pharmaceutical Inc., and Robert G. Pietrusko, Pharm.D., Chief Regulatory & Quality Officer at Vor Biopharma, provided detailed responses to questions from our audience. Tune in to hear their responses to questions around potential safety concerns to save time on long follow-ups on post- or pre-approvals and more.